CORONAVIRUS/Taiwan COVID vaccine maker says it had wanted to do stage 3 trials

06/03/2021 11:13 PM
To activate the text-to-speech service, please first agree to the privacy policy below.

Taipei, June 3 (CNA) United Biomedical, a Taiwan biopharmaceutical firm developing COVID-19 vaccines, on Thursday said it had initially planned on following international norm and entering phase 3 clinical trials before seeking government approval for its COVID-19 vaccine.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)

View All
We value your privacy.
Focus Taiwan (CNA) uses tracking technologies to provide better reading experiences, but it also respects readers' privacy. Click here to find out more about Focus Taiwan's privacy policy. When you close this window, it means you agree with this policy.